5I3E
Crystal structure of putative Putative deoxyribonuclease-2 from Burkholderia thailandensis, E264
Experimental procedure
| Experimental method | SINGLE WAVELENGTH | 
| Source type | SYNCHROTRON | 
| Source details | ALS BEAMLINE 8.2.2 | 
| Synchrotron site | ALS | 
| Beamline | 8.2.2 | 
| Temperature [K] | 100 | 
| Detector technology | CCD | 
| Collection date | 2013-09-25 | 
| Detector | ADSC QUANTUM 315 | 
| Wavelength(s) | 0.999995 | 
| Spacegroup name | P 1 21 1 | 
| Unit cell lengths | 51.160, 61.750, 102.600 | 
| Unit cell angles | 90.00, 92.12, 90.00 | 
Refinement procedure
| Resolution | 39.443 - 1.650 | 
| R-factor | 0.1557 | 
| Rwork | 0.154 | 
| R-free | 0.18660 | 
| Structure solution method | SAD | 
| RMSD bond length | 0.006 | 
| RMSD bond angle | 0.886 | 
| Data scaling software | XSCALE | 
| Phasing software | PHASER | 
| Refinement software | PHENIX | 
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 50.000 | 1.690 | |
| High resolution limit [Å] | 1.650 | 7.380 | 1.650 | 
| Rmerge | 0.052 | 0.014 | 0.523 | 
| Number of reflections | 76021 | ||
| <I/σ(I)> | 16.74 | 53.41 | 2.12 | 
| Completeness [%] | 98.7 | 93.4 | 99.5 | 
| Redundancy | 2.5 | 2.5 | |
| CC(1/2) | 0.998 | 
Crystallization Conditions
| crystal ID | method | pH | temperature | details | 
| 1 | VAPOR DIFFUSION, SITTING DROP | 6.5 | 290 | MCSG1 screen, b12: 100mM BisTris pH 6.5, 28% PEG MME 2000, trays set up at 26.5mg/ml, cryo: 15% EG; for phasing a crystal from 25% PEG 3350, 100mM BisTris pH 6.0 was incubated for 30s in a buffer containing 15% EG and 750mM NaI, iodide data were collected at the in-house source; ButhA.18065.a.B1.PS18111 at 26.5 mg/ml | 
| 1 | VAPOR DIFFUSION, SITTING DROP | 6.5 | 290 | MCSG1 screen, b12: 100mM BisTris pH 6.5, 28% PEG MME 2000, trays set up at 26.5mg/ml, cryo: 15% EG; for phasing a crystal from 25% PEG 3350, 100mM BisTris pH 6.0 was incubated for 30s in a buffer containing 15% EG and 750mM NaI, iodide data were collected at the in-house source; ButhA.18065.a.B1.PS18111 at 26.5 mg/ml | 











